Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CELLCEPT vs CERTOLIZUMAB PEGOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CELLCEPT vs CERTOLIZUMAB PEGOL: Safety Overview

Metric CELLCEPT CERTOLIZUMAB PEGOL
Total FAERS Reports 332 99,098
Deaths Reported 72 5,361
Death Rate 21.7% 5.4%
Hospitalizations 172 17,641
Average Patient Age 51.7 yrs 49.5 yrs
% Female Patients N/A 83.1%
Manufacturer N/A UCB, Inc.
Route N/A SUBCUTANEOUS
Marketing Status N/A Prescription